New fill/finish partnership with BioConnection provides end-to-end drug product development under 1 contract!   Read the press release
Contact Us
Contact Us

Press Releases

Find the latest news on AGC Biologics partnerships, product approvals, site expansions, leadership updates, new programs, and more.

2 min read

Pierre Fabre Selects AGC Biologics as CDMO to Manufacture the Orphan Drug ER-004

December 21, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics to Expand Biopharmaceutical CDMO Capacity

November 30, 2020 at 3:10 PM
Press Release
Read press release

2 min read

AGC Biologics and Horizon Therapeutics plc Expand Partnership

October 29, 2020 at 12:00 PM
Press Release
Read press release

1 min read

MolMed S.p.A Becomes AGC Biologics S.p.A Following the July Acquisition

October 27, 2020 at 4:00 PM
Press Release
Read press release

2 min read

AGC Biologics Shifts Leadership Structure at United States and Copenhagen Sites to Support the Continued Development and Growth of the Regions

October 15, 2020 at 5:00 AM
Press Release
Read press release

2 min read

AGC Biologics Appoints Luca Alberici as the New General Manager/Site Head of the Milan, Italy Site

October 12, 2020 at 5:00 AM
Press Release
Read press release

2 min read

AGC Biologics Completes PPQ Manufacturing with Provention Bio for Type 1 Diabetes Product Candidate, Teplizumab

August 25, 2020 at 7:00 AM
Press Release
Read press release

1 min read

AGC Biologics Enters into Partnership as a CDMO with Ono Pharmaceuticals to Manufacture Biopharmaceuticals at Clinical Development Stage

August 13, 2020 at 6:00 AM
Press Release
Read press release

2 min read

AGC Biologics Expands Partnership with Novavax

August 10, 2020 at 1:05 PM
Press Release
Read press release
AGC Biologics Milan facilities.

1 min read

AGC to Complete the Acquisition of MolMed on July 31, 2020

July 27, 2020 at 7:00 PM
Press Release
Read press release
Prev 6 7 8 9 10 Next